Where does Vivex Biologics Group, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vivex Biologics Group, Inc. ranks #11,513 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vivex Biologics Group, Inc. hold?

Vivex Biologics Group, Inc. holds 27 US utility patents granted between 2019 and 2025, spanning 14 technology areas.

What is Vivex Biologics Group, Inc.'s Innovation Score?

Vivex Biologics Group, Inc. has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vivex Biologics Group, Inc.'s patent grant rate increasing or decreasing?

Vivex Biologics Group, Inc.'s recent grant velocity is +633% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vivex Biologics Group, Inc.'s patents?

Vivex Biologics Group, Inc.'s patents average 12.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vivex Biologics Group, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Vivex Biologics Group, Inc.

Q: What technology areas does Vivex Biologics Group, Inc. focus on?

Vivex Biologics Group, Inc.'s top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 19 patents, ranking #143 of 2,589 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 27 granted patents across 14 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vivex ranks #11,513 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 14 technology areas.

#11,513
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 12.5
avg claims per patent: +633%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11513 · US Corporation #11,513 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,513/49,997
PHOTO-FINISH Verdesian Life…
CPC-FOCUS A61L · 14 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 12.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +633% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Verdesian Life Sciences U.S., LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vivex’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (30%) Velocity 6.2 pts (16%) Breadth 13.2 pts (34%) Claim depth 7.5 pts (20%)

Qualcomm Incorporated · highest

85
Chips & Media · near

38
NSE Products · near

38
Optex · near

38
Sakata Seed · near

38
Vivex Biologics Group · this assignee

38
3D Lighting… · lowest

7

What this shows Vivex's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vivex?

Each dot is one of Vivex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vivex’s own 12.5 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vivex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vivex's grants concentrate

Vivex Biologics Group, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 70.4% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2022 (8 grants) versus a trough of 3 in 2019. By volume, Vivex sits between Verdesian Life Sciences U.S., LLC and XConnect, LLC.

Vivex's three-year grant acceleration

Vivex Biologics Group, Inc. shows 12 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Verdesian Life Sc…

27
Verizon Telematics

27
Vertiflex

27
Vibracoustic SE

27
Wave Computing

27
Wayne/Scott Fetzer

27
Worxsafe AB

27
Xconnect

27
Vivex Biologics G… ◀

27

What this shows Vivex holds 27 patents at rank #11,509, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vivex

By rank, the assignees closest to #11,509 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Vivex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vivex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…), Vivex ranks #143 of 2,589 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

NSE Products, Inc. 38 Chips & Media, Inc 38 Optex Co., Ltd. 38 Sakata Seed Corporation 38

Vivex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Vivex Biologics Group, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	11.1%
2020	7	25.9%
2021	3	11.1%
2022	8	29.6%
2024	4	14.8%
2025partial year	2	7.4%

Which technologies does Vivex Biologics Group, Inc. patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 19

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 5

C08L - Compositions OF Macromolecular Compounds 3

A61B - DIAGNOSIS; SURGERY; Identification 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vivex Biologics Group, Inc.'s patent record in context - here's where to go next.

Vivex Biologics Group, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 70.4% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #11,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vivex Biologics Group, Inc. against Verdesian Life Sciences U.S., LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.